JP2014512403A5 - - Google Patents

Download PDF

Info

Publication number
JP2014512403A5
JP2014512403A5 JP2014506862A JP2014506862A JP2014512403A5 JP 2014512403 A5 JP2014512403 A5 JP 2014512403A5 JP 2014506862 A JP2014506862 A JP 2014506862A JP 2014506862 A JP2014506862 A JP 2014506862A JP 2014512403 A5 JP2014512403 A5 JP 2014512403A5
Authority
JP
Japan
Prior art keywords
composition
collagen
weight
total weight
monosaccharide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014506862A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014512403A (ja
JP6050320B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2012/057647 external-priority patent/WO2012146655A1/en
Publication of JP2014512403A publication Critical patent/JP2014512403A/ja
Publication of JP2014512403A5 publication Critical patent/JP2014512403A5/ja
Application granted granted Critical
Publication of JP6050320B2 publication Critical patent/JP6050320B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014506862A 2011-04-27 2012-04-26 止血組成物 Active JP6050320B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201161517973P 2011-04-27 2011-04-27
EP11305492 2011-04-27
US61/517,973 2011-04-27
EP11305492.8 2011-04-27
PCT/EP2012/057647 WO2012146655A1 (en) 2011-04-27 2012-04-26 Hemostatic compositions

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016228298A Division JP6235104B2 (ja) 2011-04-27 2016-11-24 止血組成物

Publications (3)

Publication Number Publication Date
JP2014512403A JP2014512403A (ja) 2014-05-22
JP2014512403A5 true JP2014512403A5 (enExample) 2015-06-18
JP6050320B2 JP6050320B2 (ja) 2016-12-21

Family

ID=46022222

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2014506862A Active JP6050320B2 (ja) 2011-04-27 2012-04-26 止血組成物
JP2016228298A Active JP6235104B2 (ja) 2011-04-27 2016-11-24 止血組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2016228298A Active JP6235104B2 (ja) 2011-04-27 2016-11-24 止血組成物

Country Status (15)

Country Link
US (6) US9283187B2 (enExample)
EP (3) EP2701729B1 (enExample)
JP (2) JP6050320B2 (enExample)
CN (2) CN106390186B (enExample)
AU (4) AU2012247480B2 (enExample)
BR (2) BR112013027567B1 (enExample)
CA (2) CA3108894A1 (enExample)
CY (1) CY1122251T1 (enExample)
DK (1) DK3513803T3 (enExample)
ES (1) ES2882911T3 (enExample)
PL (2) PL3513803T3 (enExample)
RS (1) RS59243B1 (enExample)
SI (1) SI2701729T1 (enExample)
SM (1) SMT201900467T1 (enExample)
WO (1) WO2012146655A1 (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102014973A (zh) 2008-02-29 2011-04-13 弗罗桑医疗设备公司 用于促进止血和/或伤口愈合的装置
US10046081B2 (en) 2008-04-11 2018-08-14 The Henry M Jackson Foundation For The Advancement Of Military Medicine, Inc. Electrospun dextran fibers and devices formed therefrom
EP2701729B1 (en) 2011-04-27 2019-05-22 Biom'up Hemostatic compositions
WO2013131520A2 (en) 2012-03-06 2013-09-12 Ferrosan Medical Devices A/S Pressurized container containing haemostatic paste
RU2636240C2 (ru) * 2012-06-12 2017-11-21 Ферросан Медикал Дивайсиз А/С Сухая гемостатическая композиция
EP3010419B1 (en) 2013-06-21 2020-05-20 Ferrosan Medical Devices A/S Vacuum expanded dry composition and syringe for retaining same
JP6489485B2 (ja) 2013-12-11 2019-03-27 フェロサン メディカル デバイシーズ エイ/エス 押し出し増強因子を含んでいる乾燥組成物
RU2546006C1 (ru) 2014-03-07 2015-04-10 Римма Ильинична Ашкинази Противовирусное средство
CA2960309A1 (en) 2014-10-13 2016-04-21 Ferrosan Medical Devices A/S Dry composition for use in haemostasis and wound healing
RU2705905C2 (ru) 2014-12-24 2019-11-12 Ферросан Медикал Дивайсиз А/С Шприц для удерживания и смешивания первого и второго веществ
US20160193381A1 (en) * 2015-01-06 2016-07-07 St. Teresa Medical, Inc. Hemostatic products
WO2016118043A1 (ru) * 2015-01-20 2016-07-28 Виктор Вениаминович ТЕЦ Гемостатическое средство
AU2016290433B2 (en) 2015-07-03 2018-05-24 Ferrosan Medical Devices A/S Syringe for mixing two components and for retaining a vacuum in a storage condition
WO2017083050A1 (en) 2015-11-12 2017-05-18 St. Teresa Medical, Inc. A method of sealing a durotomy
US11052172B2 (en) * 2016-08-12 2021-07-06 Biom'up France SAS Hemostatic flowable
EP3630082A4 (en) 2017-05-24 2021-12-15 Viktor Veniaminovich Tets FRACTIONAL ANTIMICROBIAL COMPOSITIONS AND USES THEREOF
WO2019089717A1 (en) 2017-11-02 2019-05-09 St. Teresa Medical, Inc. Fibrin sealant products
CA3090405A1 (en) * 2018-02-15 2019-08-22 Biom'up France SAS Multi-dimensional hemostatic product and method for producing the same
ES2968412T3 (es) 2018-05-09 2024-05-09 Ferrosan Medical Devices As Método para preparar una composición hemostática
CN110652648B (zh) * 2018-08-01 2021-05-28 浙江探针生物科技有限公司 输送药剂的器件及其装置和组件
KR102093839B1 (ko) * 2019-05-28 2020-05-04 (주)다림티센 지혈용 조성물 및 이를 포함하는 용기
US11027041B2 (en) * 2019-06-30 2021-06-08 James Drake Stable and robust blended hemostatic composition
JP7550390B2 (ja) 2020-05-08 2024-09-13 国立大学法人 東京大学 止血用ポリマー材料キット
KR102521769B1 (ko) * 2020-07-20 2023-04-14 주식회사 테라시온바이오메디칼 국소 지혈 파우더 조성물 및 이의 제조방법
AU2023352919A1 (en) 2022-09-29 2025-03-13 Adora Life Science, Inc. Storage stable formulations of sulfated glycosaminoglycans and fragments derived therefrom for the treatment of pain and other medical conditions

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE13810T1 (de) 1981-06-25 1985-07-15 Serapharm Gmbh & Co Kg Angereichertes plasmaderivat zur unterstuetzung von wundverschluss und wundabdeckung.
US4515637A (en) 1983-11-16 1985-05-07 Seton Company Collagen-thrombin compositions
US4942153A (en) 1987-02-03 1990-07-17 Fernandez Helen M Skin moisturizing product and process
US5681353A (en) * 1987-07-20 1997-10-28 Regen Biologics, Inc. Meniscal augmentation device
US5263984A (en) * 1987-07-20 1993-11-23 Regen Biologics, Inc. Prosthetic ligaments
IT1263394B (it) 1993-07-30 1996-08-05 Fidia Advanced Biopolymers Srl Composizioni farmaceutiche per uso topico a base di acido ialuronico e suoi derivati
DE19520575A1 (de) 1995-06-06 1996-12-12 Permselect Ges Fuer Zellstrukt Hautwirksame Kombination von Mucopolysacchariden
WO1998057678A2 (en) 1997-06-18 1998-12-23 Cohesion Technologies, Inc. Compositions containing thrombin and microfibrillar collagen
US7691829B2 (en) * 1998-03-24 2010-04-06 Petito George D Composition and method for healing tissues
US20050208114A1 (en) * 1998-03-24 2005-09-22 Petito George D Composition and method for healing tissues
WO2000010540A1 (en) 1998-08-20 2000-03-02 3M Innovative Properties Company Spray on bandage and drug delivery system
US6454787B1 (en) * 1998-12-11 2002-09-24 C. R. Bard, Inc. Collagen hemostatic foam
AT412445B (de) * 2000-06-20 2005-03-25 Biering Wolfgang Flüssiges collagen-hämostatikum
AT411326B (de) 2000-06-20 2003-12-29 Biering Wolfgang Hämostatische collagen-pellets
US20030003157A1 (en) * 2001-06-06 2003-01-02 University Of Medicine & Dentistry Of New Jersey Collagen compositions and methods for making and using the same
US6613348B1 (en) * 2001-07-31 2003-09-02 Manoj K. Jain Process of controlling absorbency in collagen flakes
JP3805654B2 (ja) 2001-08-29 2006-08-02 株式会社ネクスト 止血・癒着防止性のバイオポリマーの微細粒子
WO2003026709A1 (en) 2001-09-26 2003-04-03 Mbs Multination Business Services (G.B.) Ltd. Liquid mixture for use as a dressing spray
EP1501558A1 (de) 2002-05-08 2005-02-02 Rheinisch-Westfälische Technische Hochschule Aachen (RWTH) Resorbierbare pharmazeutische formulierung zur kontinuierlichen thrombinfreisetzung
AUPS242702A0 (en) * 2002-05-21 2002-06-13 Colltech Australia Limited Improved method for the extraction and purification of collagen
WO2005034852A2 (en) * 2003-08-26 2005-04-21 Gel-Del Technologies, Inc. Protein biomaterials and biocoacervates and methods of making and using thereof
CN1554448A (zh) 2003-12-23 2004-12-15 张淑荣 壳聚糖明胶聚乙烯醇生物止血敷料
AR054637A1 (es) * 2004-01-30 2007-07-11 Ferrosan As Aerosoles y composiciones hemostaticas
EP1731134B1 (en) * 2004-03-17 2015-10-07 Hayashibara Co., Ltd. Functional powders
EP1580229A1 (en) 2004-03-22 2005-09-28 Warner-Lambert Company Llc Biopolymer compositons and products thereof
JP4439517B2 (ja) 2004-05-13 2010-03-24 株式会社ネクスト21 経内視鏡手術に用いる止血と、癒着の防止装置
CN101001649B (zh) * 2004-07-09 2011-08-31 弗罗桑医疗设备公司 包括透明质酸的止血组合物及其制备方法
MY142987A (en) 2005-06-08 2011-02-14 Hayashibara Biochem Lab Solution for tissue adhesion prevention and method for tissue adhesion prevention
CN1709507A (zh) 2005-06-29 2005-12-21 肖春 外用复方止血镇痛消炎药
CN101272790A (zh) * 2005-09-22 2008-09-24 特罗比奥股份公司 稳定的蛋白酶组合物
JP5040234B2 (ja) 2006-09-26 2012-10-03 三菱電機株式会社 圧接型半導体装置
US8932560B2 (en) 2007-09-04 2015-01-13 University of Maryland, College Parke Advanced functional biocompatible polymeric matrix used as a hemostatic agent and system for damaged tissues and cells
WO2009073854A1 (en) * 2007-12-06 2009-06-11 Nanosys, Inc. Resorbable nanoenhanced hemostatic structures and bandage materials
CA2717571C (en) * 2008-03-03 2016-08-23 Omrix Biopharmaceuticals Ltd. A gelatin sponge comprising an active ingredient, its preparation and use
FR2944706B1 (fr) 2009-04-28 2012-08-24 Biom Up Nouveaux materiaux en collagene et procedes d'obtention.
CN101757614B (zh) * 2010-02-22 2012-04-04 苏州汇涵医用科技发展有限公司 止血剂及其制备方法
CN101837143A (zh) * 2010-04-22 2010-09-22 胡堃 一种药物缓释止血组合物及制备方法
EP2701729B1 (en) * 2011-04-27 2019-05-22 Biom'up Hemostatic compositions

Similar Documents

Publication Publication Date Title
Li et al. Nanocellulose/gelatin composite cryogels for controlled drug release
Khalil et al. Seaweed based sustainable films and composites for food and pharmaceutical applications: A review
WO2011159866A3 (en) Bone filler material
JP2011513034A5 (enExample)
JP2016094516A5 (enExample)
JP2011529463A5 (enExample)
IN2012DN03632A (enExample)
JP2019526717A5 (enExample)
JP2016527890A5 (enExample)
WO2013127598A3 (de) Verwendung von pulvercellulose in kosmetika
JP2013241609A5 (enExample)
JP2009269882A5 (enExample)
NZ603411A (en) Pazopanib compositions and their use in treating ocular diseases
WO2010006194A3 (en) Non-covalent modification of microparticles and process of preparing same
CO6571904A2 (es) Proceso para la acetilación de elementos de madera
RU2015132974A (ru) Слезозаменитель, содержащий гиалуронат натрия и карбоксиметилцеллюлозу
WO2014082951A3 (en) Oral care compositions
RU2016131243A (ru) Курительное изделие с материалом доставки жидкости
BR112015008925A2 (pt) preservação de propriedades de biomaterial e métodos de armazenamento
EP3059253A3 (en) A sulphated polysaccharide compound for the clinical use and the preparation and use thereof
JP2017057389A5 (enExample)
HK1203772A1 (en) Liquid tobacco compositions
BR112015011764A2 (pt) composições de baixo teor de sal de sódio e métodos de produção e utilização
BR112015007045A2 (pt) composição de cuidado pessoal
WO2010122258A3 (fr) Procede de fabrication de particules de poudre libre a base de polyamide impregnee d'au moins un agent cosmetique ou pharmaceutique, et particules de poudre libre a base de polyamide ayant une teneur d'au moins 25% en poids d'au moins un agent cosmetique ou pharmaceutique